×
News Home

Is it Time to Dump NovaBay Pharmaceuticals, Inc. (NBY) Stock After it Has Fallen 8.33% in a Week?

Wednesday, October 05, 2022 10:41 AM | InvestorsObserver Analysts
Is it Time to Dump NovaBay Pharmaceuticals, Inc. (NBY) Stock After it Has Fallen 8.33% in a Week?

Overall market sentiment has been down on NovaBay Pharmaceuticals, Inc. (NBY) stock lately. NBY receives a Bearish rating from InvestorsObserver Stock Sentiment Indicator.

Sentiment Score - ,bearish
NovaBay Pharmaceuticals, Inc. has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on NBY!

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor. InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon. The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With NBY Stock Today?

NovaBay Pharmaceuticals, Inc. (NBY) stock is flat -1.7% while the S&P 500 is lower by -1.72% as of 10:39 AM on Wednesday, Oct 5. NBY is unmoved $0.00 from the previous closing price of $0.11 on volume of 283,372 shares. Over the past year the S&P 500 has fallen -13.37% while NBY is lower by -81.03%. NBY lost -$0.11 per share in the over the last 12 months. To screen for more stocks like NovaBay Pharmaceuticals, Inc. click here.

More About NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare and skincare products. Its leading product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is proven in laboratory testing to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available direct to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease. Click Here to get the full Stock Report for NovaBay Pharmaceuticals, Inc. stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App